Invitrogen Posts 2-Percent Q2 Revenue Increase, Missing Estimates; Cuts '06 Outlook | GenomeWeb
NEW YORK (GenomeWeb News) - Invitrogen yesterday said that total second-quarter revenue inched up 2 percent as net income jumped 32 percent.
The company also cut its full-year 2006 revenue projection but announced a $500 million share repurchase program.
News of the revenue miss caused shares in Invitrogen to trade down 6.88 percent, or $4.29, at $58.09 early this morning.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.